Both Th1 and Th17 are immunopathogenic but differ in other key biological activities

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7414-7422

  Cox, Catherine A ^a,b   Shi, Guangpu ^a   Yin, Hongen ^a   Vistica, Barbara P ^a   Wawrousek, Eric F ^a   Chan, Chi Chao ^a   Gery, Igal ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; GAMMA INTERFERON; INTERLEUKIN 17; CD38 ANTIGEN; CD38 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CXCR3; CXCR3 PROTEIN, MOUSE; CYTOKINE; MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL HOMING; CELL SPECIFICITY; CONTROLLED STUDY; EYE INFLAMMATION; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE MIGRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; ADOPTIVE TRANSFER; ANIMAL; CELL CULTURE; CELL LINE; CELL POLARITY; EYE DISEASE; HELPER CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD38; CELL LINE; CELL POLARITY; CELLS, CULTURED; CYTOKINES; EYE DISEASES; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-17; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; RECEPTORS, CXCR3; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 46949088224     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7414     Document Type: Article

References (54)

1. H-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8: 345-350.
2. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27: 17-23.
3. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
4. Nakae, S., A. Nambu, K. Sudo, and Y. Iwakura. 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
5. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
6. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
7. Amadi-Obi, A., C.-R. Yu, X. Liu, R. M. Mahdi, G. Levy-Clark, R. B. Nussenblatt, I. Gery, Y. S. Lee, and C. E. Egwuagu. 2007. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13: 711-718.
8. Kullberg, M. C., D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203: 2485-2494.
9. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coex-pressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
10. Higgins, S. C., A. G. Jamicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177: 7980-7989.
11. Elson, C. O., Y. Cong, C. T. Weaver, T. R. Schoeb, T. K. McClanahan, R. B. Fick, and R. A. Kastelein. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gaslroenterology 132: 2359-2370.
12. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186: 307-312.
13. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188.
14. Kim, S. J., M. Zhang, B. P. Vistica, C. C. Chan, D. F. Shen, E. F. Wawrousek, and I. Gery. 2002. Induction of ocular inflammation by T-helper lymphocytes type 2. Invest. Ophthalmol. Visual Sci. 43: 758-765.
15. Uhlig, H. H., B. S. McKenzie, S. Hue, C. Thompson, B. Joyce-Shaikh, R. Stepankova, N. Robinson, S. Buonocore, H. Tlaskalova-Hogenova, D. J. Cua, and F. Powrie. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25: 309-318.
16. Wraith, D. C. 2006. Anti-cytokine vaccine and the immunotherapy of autoimmune diseases. Eur. J. Immunol. 36: 2844-2848.
17. Foxman, E. F., M. Zhang, S. D. Hurst, T. Muchamuel, D. Shen, E. F. Wawrousek, C. C. Chan, and I. Gery. 2002. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1-versus Th2-mediated ocular inflammation. J. Immunol. 168: 2483-2492.
18. Chen, J., C. Fujimoto, B. P. Vistica, E. F. Wawrousek, B. Kelsall, and I. Gery. 2006. Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J. Immunol. 177: 3362-3368.
19. Lai, J. C., A. Fukushima, E. F. Wawrousek, M. C. Lobanoff, P. Charukamnoetkanok, S. J. Smith-Gall, B. P. Vistica, R. S. Lee, C. E. Egwuagu, S. M. Whitcup, and I. Gery. 1998. lmmunotolerance against a foreign antigen transgenically expressed in the lens. Invest. Ophthalmol. Visual Sci. 39: 2049-2057.
20. H-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397.
21. Chen, J., B. P. Vistica, H. Takase, D. I. Ham, R. N. Fariss, E. F. Wawrousek, C.-C. Chan, J. A. DeMartino, J. M. Farber, and I. Gery. 2004. A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Thl cells. Eur. J. Immunol. 34: 2885-2894.
22. Sancho, D., M. Gomez, and F. Sanchez-Madrid. 2005. CD69 is an immunoregu-latory molecule induced following activation. Trends Immunol. 26: 136-140.
23. MacDonald, T. T. 1990. The role of activated T lymphocytes in gastrointestinal disease. Clin. Exp. Allergy 20: 247-252.
24. Kursar, M., U. E. Hopken, M. Koch, A. Kohler, M. Lipp, S. H. E. Kaufmann, and H.-W. Mittrucker. 2005. Differential requirements for the chemokine receptor CCR7 in T cell activation during Lisleria monocytogenes infection. J. Exp. Med. 201: 1447-1457.
25. Hove, T., F. Olle The, M. Berkhout, J. P. Bruggeman, F. A. Vyeth-Dreese, J. F. M. Slors, S. J. H. van Deventer, and A. A. te Velde. 2004. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. J. Leukocyte Biol. 75:1010-1015.
26. Ley, K., and G. S. Kansas. 2004. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4: 325-335.
27. 4-integrins in lymphocyte homing to mucosal tissues in vivo. J. Immunol. 152: 3282-3293.
28. 7 integrin. Nature 372: 190-193.
29. Sandoval-Montes, C., and L. Santos-Argumedo. 2005. CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J. Leukocyte Biol. 77: 513-521.
30. Frasca, L., G. Fedele, S. Deaglio, C. Capuano, R. Palazzo, T. Vaisitti, F. Malavasi, and C. M. Ausiello. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 107: 2392-2399.
31. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattomo, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
32. Flugel, A., T. Berkowicz, T. Ritter, M. Labeur, D. E. Jenne, Z. Li, J. W. Ellwart, M. Willem, H. Lassmann, and H. Wekerle. 2001. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547-560.
33. Steinman, L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA 93: 2253-2256.
34. Caspi, R. R., C.-C. Chan, Y. Fujino, F. Najafian, S. Graver, C. T. Hansen, and R. L. Wilder. 1993. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J. Neuroimmunol. 47: 177-188.
35. Laurence, A., C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen, Z. Yao, R. B. Blank, F. Meylan, R. Siegel, L. Hennighausen, et al. 2007. Interleukin-2 signaling via STATS constrains T helper 17 cell generation. Immunity 26: 371-381.
36. Laan, M., Z.-H. Cui, H. Hoshino, J. Lötvall, M. Sjöstrand, D. C. Gruenert, B.-E. Skoogh, and A. Lindén. 1999. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162: 2347-2352.
37. Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, and A. Jörres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO chemokine from mesothelial cells. J. Immunol. 165: 5814-5821.
38. Yoshimura, T., K.-H. Sonoda, Y. Miyazaki, Y. Iwakura, T. Ishibashi, A. Yoshimura, and H. Yoshida. 2008. Differential roles for IFN-γ and IL-17 in experimental autoimmune uveoretinitis. Int. Immunol. 20: 209-214.
39. + T cells prevents development of experimental autoimmune diseases. J. Immunol 180: 6070-6076.
40. Luger, D., P. B. Silver, J. Tung, D. Cua, Z. Coen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C.-C. Chan, and R. R. Caspi. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205: 799-810.
41. Fujimoto, G, C.-R. Yu, G. Shi, B. P. Vistica, E. F. Wawrousek, D. M. Klinman, C.-C. Chan, C. E. Egwuagu, and I. Gery. 2006. Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen by triggering robust expansion of Thl cells and their cytokine production. J. Immunol. 177: 6896-6903.
42. Hue, S., P. Ahem, S. Buonocore, M. C. Kullberg, D. J. Cua, B. S. McKenzie, F. Powrie, and K. J. Maloy. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203: 2473-2483.
43. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzhinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
44. McGeachy, M. J., and D. J. Cua. 2007. T cells doing it for themselves: TGF-β regulation of Th1 and Th17 cells. Immunity 26: 547-549.
45. Nakae, S., Y. Iwakura, H. Suto, and S. J. Galli. 2007. Phenotypic differences between Th1 and Th17 cellsand negative regulation of Th1 cell differentiation by IL-17. J. Leukocyte Biol. 81: 1258-1268.
46. Wang, Y., H. Kai, F. Chang, K. Shibata, S. Tahara-Hanaoka, S.-I. Honda, A. Shibuya, and K. Shibuya. 2007. A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 353: 857-862.
47. Shinkai, M., T. Shinkai, P. Puri, and M. D. Stringer. 2006. Increased CXCR3 expression associated with CD3-positive lymphocytes in the liver and biliary remnant in biliary atresia. J. Pediatr. Surg. 41: 950-954.
48. Franklin, R. M., and L. E. Remus. 1984. Conjunctival-associated lymphoid tissue: evidence for a role in the secretory immune system. Invest. Ophthalmol. Visual Sci. 25: 181-187.
49. Dua, H. S., J. A. Gomes, V. K. Jindal, S. N. Appa, R. Schwarting, R. C. Eagle, Jr., L. A. Donoso, and P. R. Laibson. 1994. Mucosa specific lymphocytes in the human conjunctiva, comeoscleral limbus and lacrimal gland. Curr. Eye Res. 13: 87-93.
50. Dorsey, E. R., J. P. Thompson, K. Noves, A. W. Dick, R. G. Holloway, and S. R. Schwid. 2007. Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology 68: 1524-1528.
51. Sands, B. E., R. Kozarek, J. Spainhour, C. F. Barish, S. Becker, L. Goldberg, S. Katz, R. Goldblum, R. Harrigan, D. Hilton, and S. B. Hanauer. 2007. Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab. Inflamm. Bowel Dis. 13: 2-11.
52. Iwakura, Y., and H. Ishigame. 2006. The IL-23/IL-I7 axis in inflammation. J. Clin. Invest. 116: 1218-1222.
53. Dubree, N. J. P., D. R. Artis, G. Castanedo, J. Marsters, D. Sutherlin, L. Caris, K. Clark, S. M. Keating, M. H. Beresini, H. Chiu, et al. 2002. Selective α4β7 integrin antagonists and their potential as anti-inflammatory agents. J. Med. Chem. 45: 3451-3457.
54. Zhang, M., M. S. Vacchio, B. P. Vistica, S. Lesage, C. E. Egwuagu, C.-R. Yu, M. P. Gelderman, M. C. Kennedy, E. F. Wawrousek, and I. Gery. 2003. T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form. J. Immunol. 170: 3954-3962.